Gland Pharma Limited — Updates, 09-08-2026: Press Release
09-08-2026 | 09:41 am
09-08-2026 | 09:41 am
Gland Pharma sealed a strategic CDMO partnership with a global firm for sterile injectables. This agreement covers 55 SKUs, targeting USD 90-100 million in annual revenue from 2029, significantly boosting long-term business visibility.
No comments yet. Be the first to comment!
